Department of General, Visceral, and Vascular Surgery, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Int J Colorectal Dis. 2021 Sep;36(9):1937-1943. doi: 10.1007/s00384-021-03981-z. Epub 2021 Jun 23.
Functional results after proctocolectomy and ileal pouch-anal anastomosis (IPAA) are generally good. However, some patients suffer from high stool frequency or fecal incontinence. Sacral nerve stimulation (SNS) may represent a therapeutic alternative in these patients, but little is known about indication and results. The aim of this study was to evaluate incontinence after IPAA and demonstrate SNS feasibility in these patients.
This retrospective study includes patients who received a SNS between 1993 and 2020 for increased stool frequency or fecal incontinence after proctocolectomy with IPAA for ulcerative colitis. Proctocolectomy was performed in a two- or three-step approach with ileostomy closure as the last step. Demographic, follow-up data and functional results were obtained from the hospital database.
SNS was performed in 23 patients. Median follow-up time after SNS was 6.5 years (min. 4.2-max. 8.8). Two patients were lost to follow-up. The median time from ileostomy closure to SNS implantation was 6 years (min. 0.5-max. 14.5). Continence after SNS improved in 16 patients (69%) with a median St. Marks score for anal incontinence of 19 (min. 4-max. 22) before SNS compared to 4 (0-10) after SNS placement (p = 0.012). In seven patients, SNS therapy was not successful.
SNS implantation improves symptoms in over two-thirds of patients suffering from high stool frequency or fecal incontinence after proctocolectomy with IPAA. Awareness of the beneficial effects of SNS should be increased in physicians involved in the management of these patients.
直肠结肠切除和回肠袋肛管吻合术(IPAA)后的功能结果通常较好。然而,一些患者存在高排便频率或粪便失禁。骶神经刺激(SNS)可能是这些患者的一种治疗选择,但对其适应证和结果知之甚少。本研究旨在评估 IPAA 后失禁情况,并证明 SNS 在这些患者中的可行性。
本回顾性研究纳入了 1993 年至 2020 年间因溃疡性结肠炎直肠结肠切除和 IPAA 后排便频率增加或粪便失禁而接受 SNS 治疗的患者。直肠结肠切除术采用两步或三步法进行,最后一步为回肠造口关闭。从医院数据库中获取人口统计学、随访数据和功能结果。
23 例患者接受了 SNS 治疗。SNS 后中位随访时间为 6.5 年(最小 4.2-最大 8.8 年)。2 例患者失访。从回肠造口关闭到 SNS 植入的中位时间为 6 年(最小 0.5-最大 14.5 年)。SNS 治疗后,16 例(69%)患者的控便能力得到改善,SNS 治疗前肛门失禁 St. Marks 评分中位数为 19(最小 4-最大 22),而 SNS 植入后为 4(0-10)(p=0.012)。在 7 例患者中,SNS 治疗无效。
在接受直肠结肠切除和 IPAA 治疗后出现高排便频率或粪便失禁的患者中,超过三分之二的患者接受 SNS 植入后症状得到改善。应提高参与这些患者管理的医生对 SNS 有益效果的认识。